CRL
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCHCharles River Laboratories International, Inc. Common Stock (CRL) [ST]
www.criver.com ↗▲ 0.00%
prev close
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Congressional Trades
4
All tracked trades
Members Trading
4
Unique members
Net Activity
+2
3 buys · 1 sells
Members Who Traded This Stock
4 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2025-05-08 | CRLCharles River Laboratories International, Inc. Common Stock | Buy | $15,001 - $50,000 | 346d ago | — | |
| 2025-04-08 | CRLCharles River Laboratories International, Inc. Common Stock | Buy | $15,001 - $50,000 | 391d ago | — | |
| 2025-01-15 | CRLCharles River Laboratories International, Inc. Common Stock | Buy | $1,001 - $15,000 | 476d ago | — | |
| 2023-09-08 | CRLCharles River Laboratories International, Inc. Common Stock | Sell | $1,001 - $15,000 | 967d ago | — |
2025-05-08
Jefferson Shreve
CRL
Amount
$15,001 - $50,000
Filed
346d ago
2025-04-08
Rob Bresnahan
CRL
Amount
$15,001 - $50,000
Filed
391d ago
2025-01-15
Julie Johnson
CRL
Amount
$1,001 - $15,000
Filed
476d ago
2023-09-08
Lois Frankel
CRL
Amount
$1,001 - $15,000
Filed
967d ago
Recent News
Powered by Polygon.io
Cell Banking Outsourcing Market: 16%+ CAGR (2026-2031), Expanding with Rising Demand for Biologics and Regenerative Medicine Services, Says Mordor Intelligence
Global Plasmid DNA Manufacturing Market Anticipates Impressive Growth Trajectory at a CAGR of ~18% by 2034 | DelveInsight
Global AAV Vector Manufacturing Market Gearing Up for Outstanding Expansion at a CAGR of ~22% by 2034 | DelveInsight
Drug Development Services Market Research Report 2026: $50+ Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
Practical Implementation of GCP in Veterinary Course: Approaches to the Design, Set-up and Conduct in Compliance with VICH Good Clinical Practice (GCP) Principles (ONLINE EVENT: May 13th-14th, 2026)
Trade Timeline
Congressional activity, newest first
Jefferson Shreve
2025-05-08 · Purchase
$15,001 - $50,000
Rob Bresnahan
2025-04-08 · Purchase
$15,001 - $50,000
Julie Johnson
2025-01-15 · Purchase
$1,001 - $15,000
Lois Frankel
2023-09-08 · Sale
$1,001 - $15,000